Literature DB >> 6625700

Arthritis and angioimmunoblastic lymphadenopathy.

P G Davies, J N Fordham.   

Abstract

We report 2 contrasting cases of a seronegative polyarthritis associated with angioimmunoblastic lymphadenopathy (AILD). Both cases were nonerosive, with symmetrical involvement of the elbows, wrists, knees, and ankles. In one the arthritis appeared concurrently with the main systemic manifestations of AILD. The second presented with polyarthritis 18 months before the onset of AILD. This patient received azathioprine for 11 months before developing AILD, which raises the possibility of this drug being the causative agent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6625700      PMCID: PMC1001286          DOI: 10.1136/ard.42.5.516

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  [Developmental aspects of angioimmunoblastic lymphadenopathy. Apropos of 3 cases].

Authors:  H Rochant; F Reyes; J P Vernant; B Brun; A Schaeffer; C Sultan; M Tulliez; M Lebezu; B Dreyfus
Journal:  Ann Med Interne (Paris)       Date:  1976-11

2.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

3.  Selective hypoaldosteronism. An editorial revisited after 15 years.

Authors:  M F Michelis; H V Murdaugh
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

4.  [Immunoblastic adenopathy: clinical features, treatment and prognosis (author's transl)].

Authors:  T Radaszkiewicz; K Lennert
Journal:  Dtsch Med Wochenschr       Date:  1975-05-23       Impact factor: 0.628

5.  (Angio) immunoblastic lymphadenopathy. A presentation of 5 cases.

Authors:  R Goudsmit; P Van Heerde; A C Jöbsis; A E Borne; R Somers
Journal:  Neth J Med       Date:  1976       Impact factor: 1.422

6.  Angioimmunoblastic lymphadenopathy: an immunochemical study.

Authors:  W Pruzanski; D M Sutton; D Pantalony
Journal:  Clin Immunol Immunopathol       Date:  1976-07

7.  [Angioimmunoblastic lymphadenopathies with autoimmune anemia and polyclonal hyperimmunoglobulinemia].

Authors:  G Flandrin
Journal:  Nouv Presse Med       Date:  1976-06-12

8.  Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes.

Authors:  R A Rudders; R DeLellis
Journal:  Am J Clin Pathol       Date:  1977-10       Impact factor: 2.493

9.  Letter: Levamisole in angio-immunoblastic lymphadenopathy.

Authors:  J Bensa; J Faure; H Martin; J Sotto; R Schaerer
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

10.  [Angio-immunoblastic lymphadenopathy with dysproteinemia. Apropos of 5 cases].

Authors:  P Dujardin; P Audoly; J P Cassuto; J Kermarec
Journal:  Sem Hop       Date:  1977-06-23
View more
  3 in total

1.  Arthritis and angioimmunoblastic lymphadenopathy.

Authors:  J C Duró
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

2.  Polyarthritis and angioimmunoblastic lymphadenopathy.

Authors:  N J McHugh; G J Campbell; J J Landreth; M R Laurent
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

3.  Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and sicca syndrome.

Authors:  Y J Bignon; A Janin-Mercier; J J Dubost; J M Ristori; Y Fonck; J C Alphonse; B J Sauvezie
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.